Foundayo (orforglipron) is Eli Lilly's oral GLP-1 pill for weight loss — the first GLP-1 you can take as a once-daily tablet with no food or water restrictions. It was FDA approved April 1, 2026, costs $149/month cash through LillyDirect (or as little as $50/month on the new Medicare Bridge), and in the ATTAIN-1 trial the highest dose produced up to 12.4% average body-weight loss (about 27 lbs). That's real, but less than injectable tirzepatide (Zepbound, ~20%) or semaglutide (Wegovy, ~15%). The trade is convenience and cash price for peak results.
Here's everything that actually matters: what it is, how well it works, the full cost picture, the dosage schedule, side effects, how it stacks up against the injectables, how to get it, and who the pill is right for.
What is Foundayo (orforglipron)?
Foundayo is the brand name; orforglipron is the drug. It's a once-daily oral GLP-1 receptor agonist from Eli Lilly — and unlike Rybelsus (oral semaglutide, which needs an empty stomach and a strict water-and-timing routine), Foundayo is a small-molecule "non-peptide" pill you can take any time of day, with or without food. That's the headline: it's the first GLP-1 that fits into a normal day like any other medication.
It was FDA approved on April 1, 2026 for chronic weight management in adults with obesity (BMI ≥ 30), or overweight (BMI ≥ 27) with a weight-related condition. LillyDirect began shipping it on April 6, 2026.
How well does Foundayo work for weight loss?
In the ATTAIN-1 phase 3 trial, people on the highest dose who stayed on treatment lost an average of 12.4% of body weight (about 27 lbs) versus 0.9% on placebo. Up to 51.5% of women in ATTAIN-1 reached 15% or more weight loss.
Put in context with the other GLP-1s:
| Medication | Type | Avg weight loss |
|---|---|---|
| Zepbound / Mounjaro (tirzepatide) | Injectable | 20–22% |
| Wegovy (semaglutide) | Injectable | 15–17% |
| Foundayo (orforglipron) | Oral pill | up to ~12% |
| Ozempic (semaglutide) | Injectable | 8–14% |
| Rybelsus (oral semaglutide) | Oral pill | 5–10% |
So Foundayo is the most effective oral GLP-1 to date — it clearly beats Rybelsus — but it doesn't match injectable tirzepatide. The right question isn't "which number is biggest," it's "which one will I actually take for 12+ months," and for many people a daily pill wins over a weekly needle.
How much does Foundayo cost?
Foundayo costs $149/month cash through LillyDirect with no insurance — dramatically cheaper than injectable brands, which list at $1,000–$1,350/month. With coverage it can be far less:
- Cash (no insurance): $149/month via LillyDirect — Lilly priced the pill aggressively to compete with compounded GLP-1s.
- Medicare: $50/month — Foundayo is one of three drugs covered under the Medicare GLP-1 Bridge, which runs through December 31, 2027.
- Commercial insurance: roughly $25/month with a savings card if your plan covers weight-loss drugs.
For scale, that $149 cash price is close to what verified telehealth providers charge for compounded GLP-1s — compounded semaglutide runs $69–$99/month and compounded tirzepatide $119–$149. The difference is Foundayo is a brand-name FDA-approved pill, while the compounded options are injectables prescribed by telehealth clinicians. See the full breakdown on our GLP-1 Price Index.
What is the Foundayo dosage and titration schedule?
Everyone starts at 0.8 mg once daily and steps up every 4 weeks — to 5.5 mg, then 9 mg, then a maximum of 17.2 mg — to build tolerance and reduce side effects. The 0.8 mg starter is not a treatment dose; it exists to let your gut adjust.
- Weeks 1–4: 0.8 mg daily (starter dose)
- Every 4 weeks after: step up as tolerated toward your target — 5.5 mg, 9 mg, or 17.2 mg
- Take it once daily, any time, with or without food or water
Higher doses drive more weight loss but more GI side effects, so your prescriber titrates to the lowest dose that works for you rather than automatically pushing to 17.2 mg.
What are Foundayo's side effects?
Foundayo's side effects are the familiar GLP-1 class effects — mostly gastrointestinal and mostly early: nausea, diarrhea, constipation, vomiting, and reduced appetite. They're usually worst in the first weeks after a dose increase and settle as your body adjusts, which is exactly why the titration is gradual.
The management playbook is the same as for injectable GLP-1s: eat smaller, lower-fat meals, stay hydrated, and don't rush dose increases. Serious side effects (pancreatitis, gallbladder problems, severe allergic reactions) are rare but warrant stopping and calling your prescriber. Like all GLP-1s, it carries the class boxed warning about thyroid C-cell tumors seen in rodent studies.
Foundayo vs Zepbound vs Wegovy: which should you choose?
Choose Foundayo if you want a pill and prioritize convenience and cash price; choose an injectable (Zepbound, Wegovy, or compounded tirzepatide) if you want maximum weight loss. The molecule you'll stick with beats the one you quit.
- Foundayo vs Zepbound: Zepbound (tirzepatide) wins on raw efficacy (~20% vs ~12%) but is a weekly injection at a higher list price. Foundayo wins on convenience and the $149 cash price.
- Foundayo vs Wegovy: a closer fight — Wegovy edges it on efficacy (~15% vs ~12%) and is also a weekly injection.
- Foundayo vs compounded: compounded semaglutide/tirzepatide from telehealth is injectable but often cheaper than $149 and, for tirzepatide, more effective. If you're open to injections, compare the cheapest verified programs — several beat Foundayo on both price and results.
If needles are the dealbreaker, Foundayo is the clear best-in-class oral option. If they're not, an injectable — brand or compounded — usually gets you more weight loss per dollar.
How do you get Foundayo?
You get Foundayo with a prescription from any licensed US provider, then fill it through LillyDirect (Lilly's own pharmacy), a telehealth service, or a retail pharmacy. The fastest cash route is LillyDirect at $149/month. A telehealth visit can produce a prescription in about 10 minutes online if you qualify (BMI ≥ 30, or ≥ 27 with a comorbidity).
If you don't qualify for Foundayo, can't get it covered, or want a more effective option, telehealth compounded GLP-1 programs are the common alternative — see our full provider comparison.
Is Foundayo covered by insurance or Medicare?
Yes for many: Foundayo is covered under the Medicare GLP-1 Bridge at $50/month, and by commercial plans that cover weight-loss drugs (often ~$25/month with a savings card). But like all weight-loss GLP-1s, plenty of commercial plans exclude obesity medications entirely — in which case the $149 LillyDirect cash price is the fallback, and it's low enough that many people simply pay cash. Medicaid coverage varies by state; check our Medicaid GLP-1 guide.
Frequently asked questions
Is Foundayo the same as orforglipron? Yes. Foundayo is the brand name; orforglipron is the active drug — a non-peptide oral GLP-1 from Eli Lilly.
Is Foundayo as good as Ozempic or Wegovy? For weight loss, Foundayo (~12%) lands between Ozempic (8–14%) and just under Wegovy (15%). It's less effective than tirzepatide (Zepbound/Mounjaro, ~20%). Its advantage is being an easy daily pill at a low cash price.
Do you have to take Foundayo on an empty stomach? No. Unlike Rybelsus, Foundayo has no food or water restrictions — take it any time of day.
How much weight can you lose on Foundayo? In trials, up to 12.4% of body weight at the top dose over the study period, with over half of some groups reaching 15%+. Individual results vary with dose, adherence, and lifestyle.
Is Foundayo cheaper than compounded semaglutide? Roughly comparable. Foundayo is $149/month cash; verified compounded semaglutide starts around $69–$99/month and compounded tirzepatide around $119–$149 — but those are injectables. See the GLP-1 Price Index.
When was Foundayo approved? April 1, 2026, by the FDA, for chronic weight management. It began shipping via LillyDirect on April 6, 2026.
Bottom line
Foundayo (orforglipron) is a genuine milestone: the first GLP-1 pill that works like a normal daily medication, at a cash price ($149) that undercuts every injectable brand. It won't out-lose tirzepatide, but "the drug you'll actually stay on" matters more than the peak number — and for people who won't do injections, Foundayo is the best oral option available.
If maximum results matter more than avoiding needles, an injectable — brand Zepbound or a cheaper compounded tirzepatide program — will usually deliver more weight loss for the money. Compare every verified path on our best GLP-1 providers list and the GLP-1 Price Index.